Uncategorized

Bora inks $122.5M takeover of MacroGenics facility to further US expansion

Published

on

MacroGenics is selling the manufacturing plant to Bora, a Taiwan-based CDMO, to raise cash to support the progress of its drug development pipeline.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version